USANA Health Sciences, Inc.
Price Action
Technical Summary
CONSOLIDATINGUSANA Health Sciences, Inc. is in a consolidation phase, trading with mixed signals as moving averages converge. Relative strength is moderate (RS Rating: 59), indicating performance broadly in line with the market. Earnings contraction of 16% provides fundamental context to the price action. Volume support will be critical for the stock to resolve this consolidation to the upside.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $20.03 | +11.75% | ABOVE |
| 50 SMA | $19.11 | +17.08% | ABOVE |
| 100 SMA | $18.95 | +18.10% | ABOVE |
| 150 SMA | $19.49 | +14.83% | ABOVE |
| 200 SMA | $20.26 | +10.48% | ABOVE |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is USNA in an uptrend right now?
USNA has a trend score of 2/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 2 of 4 trend criteria are met.
Is USNA overbought or oversold?
USNA's RSI (14) is 69. The stock is in neutral territory, neither overbought nor oversold.
Is USNA outperforming the market?
USNA has a Relative Strength (RS) Rating of 59 out of 99. USNA is performing about average compared to the market.
Where is USNA in its 52-week range?
USNA is trading at $22.38, which is 58% of its 52-week high ($38.32) and 27% above its 52-week low ($16.60).
How volatile is USNA?
USNA has a Beta of 1.21 and 52-week volatility of 47%. It's more volatile than the S&P 500 - expect bigger swings.